Fragments of gD Protein as Inhibitors of BTLA/HVEM Complex Formation - Design, Synthesis, and Cellular Studies

One of the major current trends in cancer immunotherapy is the blockade of immune checkpoint proteins that negatively regulate the immune response. This has been achieved through antibodies blocking PD-1/PD-L1 and CTLA-4/CD80/CD86 interactions. Such antibodies have revolutionized oncological therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuncewicz, Katarzyna, Battin, Claire, Sieradzan, Adam, Karczyńska, Agnieszka, Orlikowska, Marta, Wardowska, Anna, Pikuła, Michał, Steinberger, Peter, Rodziewicz-Motowidło, Sylwia, Spodzieja, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700651/
https://www.ncbi.nlm.nih.gov/pubmed/33238640
http://dx.doi.org/10.3390/ijms21228876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700651/
https://www.ncbi.nlm.nih.gov/pubmed/33238640
http://dx.doi.org/10.3390/ijms21228876

Ejemplares similares